WAT
61
-3
SHW
53
-2
DOW
36
-2
PM
50
-4
FIS
50
4
TSN
32
-3
EXPD
39
-11
UA
56
3
LH
36
-3
RRC
63
8
RF
48
-3
CNX
76
5
HAL
41
2
NTRS
35
-14
MCD
57
-5
GME
57
5
HIG
54
2
HSY
38
-7
ITW
58
-4
XEL
53
-2
WAT
61
-3
SHW
53
-2
DOW
36
-2
PM
50
-4
FIS
50
4
TSN
32
-3
EXPD
39
-11
UA
56
3
LH
36
-3
RRC
63
8
RF
48
-3
CNX
76
5
HAL
41
2
NTRS
35
-14
MCD
57
-5
GME
57
5
HIG
54
2
HSY
38
-7
ITW
58
-4
XEL
53
-2
Financhill
Back

Revolution Medicines Vs. Perspective Therapeutics Industry Stock Comparison

Sell
49

RVMD
Revolution Medicines

Last Price:
46.06
Seasonality Move:
-1.21%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.47
Seasonality Move:
22.12%
Sell
49
Revolution Medicines (RVMD) is a Sell

Is Revolution Medicines a Buy, Sell or Hold?

  • The current Revolution Medicines [RVMD] share price is $46.43. The Score for RVMD is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • RVMD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.45. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RVMD Stock Price Chart

What is Revolution Medicines's stock price today?

  • The Revolution Medicines share price today is $46.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVMD is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

RVMD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.82 Sell
Relative Strength Index (14 RSI): 31.86 Sell
Chaikin Money Flow: -1195545 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.86 - 59.56) Sell
Bollinger Bands (100): (42.48 - 53.42) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.79 Sell
Relative Strength Index (14 RSI): 21.95 Sell
Chaikin Money Flow: -1254860 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.15 - 9.41) Sell
Bollinger Bands (100): (7.96 - 15.18) Sell

RVMD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.05 Sell
20-day SMA: 53.45 Sell
50-day SMA: 52.1 Sell
200-day SMA: 42.32 Buy
8-day EMA: 48.81 Sell
20-day EMA: 51.62 Sell
50-day EMA: 51.31 Sell
200-day EMA: 43.4 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.78 Sell
20-day SMA: 4.99 Sell
50-day SMA: 9.38 Sell
200-day SMA: 12.42 Sell
8-day EMA: 3.85 Sell
20-day EMA: 5.31 Sell
50-day EMA: 8.21 Sell
200-day EMA: 10.51 Sell

Revolution Medicines Earnings Growth & RVMD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.46 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

Revolution Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):